Biora Financial Statements From 2010 to 2024
| BIOR Stock | USD 1.93 0.14 7.82% |
Check Biora Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biora Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Biora financial statements analysis is a perfect complement when working with Biora Therapeutics Valuation or Volatility modules.
Biora |
Biora Therapeutics Company Shares Outstanding Analysis
Biora Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biora Therapeutics Shares Outstanding | 4.52 M |
Most of Biora Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biora Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biora Therapeutics has 4.52 M of shares currently outstending. This is 97.49% lower than that of the Biotechnology sector and 95.77% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.21% higher than that of the company.
Biora Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biora Therapeutics's current stock value. Our valuation model uses many indicators to compare Biora Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biora Therapeutics competition to find correlations between indicators driving Biora Therapeutics's intrinsic value. More Info.Biora Therapeutics is rated below average in return on asset category among its peers. It is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Biora Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Biora Therapeutics Financial Statements
Biora Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Biora Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Biora Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Biora Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. Biora Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.
Pair Trading with Biora Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biora Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Biora Stock
| 0.78 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Biora Stock
| 0.75 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.71 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.65 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.43 | PHVS | Pharvaris BV | PairCorr |
| 0.38 | PLRX | Pliant Therapeutics | PairCorr |
The ability to find closely correlated positions to Biora Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biora Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biora Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biora Therapeutics to buy it.
The correlation of Biora Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biora Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biora Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biora Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.